Open AccessThe evolution of personalized healthcare and the pivotal role of European regions in its implementation
Author(s) -
Christine Nardini,
Venet Osmani,
Paola Giulia Cormio,
Andrea Frosini,
Mauro Turrini,
Christos Lionis,
Thomas Neumuth,
Wolfgang Ballensiefen,
Elio Borgonovi
Publication year - 2021
Publication title -
personalized medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.489
H-Index - 31
eISSN - 1744-828X
pISSN - 1741-0541
DOI - 10.2217/pme-2020-0115
Subject(s) - pace , personalized medicine , health care , stakeholder , business , healthcare delivery , key (lock) , knowledge management , medicine , public relations , political science , computer science , bioinformatics , geography , computer security , geodesy , law , biology
Personalized medicine (PM) moves at the same pace of data and technology and calls for important changes in healthcare. New players are participating, providing impulse to PM. We review the conceptual foundations for PM and personalized healthcare and their evolution through scientific publications where a clear definition and the features of the different formulations are identifiable. We then examined PM policy documents of the International Consortium for Personalised Medicine and related initiatives to understand how PM stakeholders have been changing. Regional authorities and stakeholders have joined the race to deliver personalized care and are driving toward what could be termed as the next personalized healthcare. Their role as a key stakeholder in PM is expected to be pivotal.